Cas:80296-93-1 Carboxymethylcellulose sodium salt manufacturer & supplier

Chemical Name:Carboxymethylcellulose sodium salt

CAS.NO:80296-93-1

Synonyms:Ethanoic Acid;2,3,4,5,6-Pentahydroxyhexanal;Sodium;Carboxymethyl Cellulose;Carboxymethylcellulose

Molecular Formula:C₈H₁₆NaO₈

Molecular Weight:263.2

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Ethanoic Acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Carboxymethylcellulose physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Carboxymethylcellulose Use and application,2,3,4,5,6-Pentahydroxyhexanal technical grade,usp/ep/jp grade.

Related News: ��Once these risks have been identified then a project team can be put together combining the necessary expertise to provide the integrated services and tailored support to ensure continuity of supply from beginning to end.�� Carboxymethylcellulose sodium salt manufacturer Alira is betting big on biometrics services by picking up Italy-based CROS NT, which has offices in Italy, London and North Carolina. The deal, for undisclosed terms, gives a boost to Alira’s direct clinical operations in Europe and access to biometrics services from the 29-year-old contract research organization. Carboxymethylcellulose sodium salt supplier ICIG is a privately owned industrial holding company focusing on mid-sized chemicals and pharmaceutical businesses. Carboxymethylcellulose sodium salt vendor Alira is betting big on biometrics services by picking up Italy-based CROS NT, which has offices in Italy, London and North Carolina. The deal, for undisclosed terms, gives a boost to Alira’s direct clinical operations in Europe and access to biometrics services from the 29-year-old contract research organization. Carboxymethylcellulose sodium salt factory The Company��s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.